Application of Chinese Medicine in Treatment of Ulcerative Colitis and Elucidation of Relevant Mechanisms

Overview

Journal Chin J Integr Med

Date 2025 Jan 17

PMID 39821880

Authors

Ji-Wei Zhu

Han-Ming Wang

Muaitaer Aisikaer

Wen-Jun Zhou

Tong-Tong Yang

Kasimujiang Aximujiang

Affiliations

Soon will be listed here.

Abstract

Ulcerative colitis (UC) is a chronic, non-specific intestinal disease of unknown etiology, with high incidence rates worldwide. At present, Western medicine treatments have been associated with more adverse effects and poor efficacy. Chinese medicine (CM) is commonly used as an adjuvant treatment for the unique advantages in regulating immune function, repairing intestinal mucosa, and alleviating intestinal inflammation. At the same time, network pharmacology is also providing new ideas and innovations about CM and development of new drugs. This review systematically discusses the progress of research regarding UC treatment using CM, with a main focus on intestinal flora balance, intestinal mucosal barrier, CM enema, acupuncture therapy, and acupoint embedding. This study provides new ideas that clarify the therapeutic targets of UC.

References

Colombel J, Sands B, Rutgeerts P, Sandborn W, Danese S, DHaens G . The safety of vedolizumab for ulcerative colitis and Crohn's disease. Gut. 2016; 66(5):839-851. PMC: 5531223. DOI: 10.1136/gutjnl-2015-311079. View

Du L, Ha C . Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am. 2020; 49(4):643-654. DOI: 10.1016/j.gtc.2020.07.005. View

Yan Y, Ren F, Wang P, Sun Y, Xing J . Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis. Iran J Basic Med Sci. 2020; 22(12):1452-1461. PMC: 7043877. DOI: 10.22038/IJBMS.2019.13991. View

Liu C, Hua H, Zhu H, Cheng Y, Guo Y, Yao W . Aloe polysaccharides ameliorate acute colitis in mice via Nrf2/HO-1 signaling pathway and short-chain fatty acids metabolism. Int J Biol Macromol. 2021; 185:804-812. DOI: 10.1016/j.ijbiomac.2021.07.007. View

Jeon Y, Bang K, Shin M, Lee J, Chang Y, Jin J . Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitis. BMC Complement Altern Med. 2016; 16(1):459. PMC: 5111347. DOI: 10.1186/s12906-016-1390-8. View

Cui H, Cai Y, Wang L, Jia B, Li J, Zhao S . Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon. Front Pharmacol. 2018; 9:571. PMC: 5991375. DOI: 10.3389/fphar.2018.00571. View

Lin Z, Wu H, Fu Y, Dai S . Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy. Inflamm Bowel Dis. 2019; 25(12):1886-1895. DOI: 10.1093/ibd/izz190. View

Yu T, Feng Y, Kong W, Li S, Sun X, Zhou G . Gallic acid ameliorates dextran sulfate sodium-induced ulcerative colitis in mice inhibiting NLRP3 inflammasome. Front Pharmacol. 2023; 14:1095721. PMC: 9905138. DOI: 10.3389/fphar.2023.1095721. View

Zegarra-Ruiz D, Kim D, Norwood K, Kim M, Wu W, Saldana-Morales F . Thymic development of gut-microbiota-specific T cells. Nature. 2021; 594(7863):413-417. PMC: 8323488. DOI: 10.1038/s41586-021-03531-1. View

10.

Lavelle A, Sokol H . Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020; 17(4):223-237. DOI: 10.1038/s41575-019-0258-z. View

11.

Yang S, Shang J, Liu L, Tang Z, Meng X . Strains producing different short-chain fatty acids alleviate DSS-induced ulcerative colitis by regulating intestinal microecology. Food Funct. 2022; 13(23):12156-12169. DOI: 10.1039/d2fo01577c. View

12.

Bao X, Feng Z, Yao J, Li T, Yin Y . Roles of Dietary Amino Acids and Their Metabolites in Pathogenesis of Inflammatory Bowel Disease. Mediators Inflamm. 2017; 2017:6869259. PMC: 5368367. DOI: 10.1155/2017/6869259. View

13.

Yu Z, Li D, Sun H . Herba Origani alleviated DSS-induced ulcerative colitis in mice through remolding gut microbiota to regulate bile acid and short-chain fatty acid metabolisms. Biomed Pharmacother. 2023; 161:114409. DOI: 10.1016/j.biopha.2023.114409. View

14.

Kriaa A, Mariaule V, Jablaoui A, Rhimi S, Mkaouar H, Hernandez J . Bile Acids: Key Players in Inflammatory Bowel Diseases?. Cells. 2022; 11(5). PMC: 8909766. DOI: 10.3390/cells11050901. View

15.

Yang M, Gu Y, Li L, Liu T, Song X, Sun Y . Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside. Nutrients. 2021; 13(9). PMC: 8467364. DOI: 10.3390/nu13093143. View

16.

Aximujiang K, Kaheman K, Wushouer X, Wu G, Ahemaiti A, Yunusi K . and HKL Suspension Alleviates Ulcerative Colitis in Rats by Regulating Gut Microbiota, Suppressing TLR9, and Promoting Metabolism. Front Pharmacol. 2022; 13:859628. PMC: 9118348. DOI: 10.3389/fphar.2022.859628. View

17.

Nishida A, Ochman H . A great-ape view of the gut microbiome. Nat Rev Genet. 2019; 20(4):195-206. DOI: 10.1038/s41576-018-0085-z. View

18.

Zuo T, Lu X, Zhang Y, Cheung C, Lam S, Zhang F . Gut mucosal virome alterations in ulcerative colitis. Gut. 2019; 68(7):1169-1179. PMC: 6582748. DOI: 10.1136/gutjnl-2018-318131. View

19.

Chen F, Yin Y, Zhao H, Wang H, Zhong Y, Long J . Sishen Pill Treatment of DSS-Induced Colitis Regulating Interaction With Inflammatory Dendritic Cells and Gut Microbiota. Front Physiol. 2020; 11:801. PMC: 7381313. DOI: 10.3389/fphys.2020.00801. View

20.

Wu Y, Li Y, Ruan Z, Li J, Zhang L, Lu H . Puerarin Rebuilding the Mucus Layer and Regulating Mucin-Utilizing Bacteria to Relieve Ulcerative Colitis. J Agric Food Chem. 2020; 68(41):11402-11411. DOI: 10.1021/acs.jafc.0c04119. View